{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:30:25Z","timestamp":1780050625584,"version":"3.53.1"},"reference-count":27,"publisher":"Japan Atherosclerosis Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2025,12,1]]},"DOI":"10.5551\/jat.65784","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T22:08:03Z","timestamp":1755814083000},"page":"1613-1623","source":"Crossref","is-referenced-by-count":1,"title":["Short-Term Treatment for Immune-Mediated Acquired Lecithin\u2013Cholesterol Acyltransferase Deficiency Restores the High-Density Lipoprotein Function: A Case Report"],"prefix":"10.5551","volume":"32","author":[{"given":"Tomohiro","family":"Komatsu","sequence":"first","affiliation":[{"name":"Division of Antiaging and Vascular Medicine, Department of Internal Medicine, National Defense Medical College"},{"name":"Center for Preventive, Antiaging and Regenerative Medicine, Fukuoka University Hospital"},{"name":"Research Institute for Physical Activity, Fukuoka University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satomi","family":"Abe","sequence":"additional","affiliation":[{"name":"Research Institute for Physical Activity, Fukuoka University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Kuroda","sequence":"additional","affiliation":[{"name":"Center for Advanced Medicine, Chiba University Hospital, Chiba University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Endo","sequence":"additional","affiliation":[{"name":"Division of Antiaging and Vascular Medicine, Department of Internal Medicine, National Defense Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Division of Antiaging and Vascular Medicine, Department of Internal Medicine, National Defense Medical College"},{"name":"Center for Preventive, Antiaging and Regenerative Medicine, Fukuoka University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Nishida","sequence":"additional","affiliation":[{"name":"Division of Antiaging and Vascular Medicine, Department of Internal Medicine, National Defense Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manami","family":"Teramoto","sequence":"additional","affiliation":[{"name":"Division of Antiaging and Vascular Medicine, Department of Internal Medicine, National Defense Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Arakawa","sequence":"additional","affiliation":[{"name":"Division of Antiaging and Vascular Medicine, Department of Internal Medicine, National Defense Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"kuwata","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Endocrinology, Department of Internal Medicine, National Defense Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Imakiire","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Endocrinology, Department of Internal Medicine, National Defense Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiro","family":"Maezawa","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hematology and Gerontology, Chiba University Graduate School of Medicine, Chiba University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koutaro","family":"Yokote","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hematology and Gerontology, Chiba University Graduate School of Medicine, Chiba University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinari","family":"Uehara","sequence":"additional","affiliation":[{"name":"Center for Preventive, Antiaging and Regenerative Medicine, Fukuoka University Hospital"},{"name":"Research Institute for Physical Activity, Fukuoka University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Ikewaki","sequence":"additional","affiliation":[{"name":"Division of Antiaging and Vascular Medicine, Department of Internal Medicine, National Defense Medical College"},{"name":"Tokorozawa Heart Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR: High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med, 1977; 62: 707-714","DOI":"10.1016\/0002-9343(77)90874-9"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Kosugi T, Eriguchi M, Yoshida H, Tamaki H, Uemura T, Tasaki H, Furuyama R, Fukata F, Nishimoto M, Matsui M, Samejima KI, Iseki K, Fujimoto S, Konta T, Moriyama T, Yamagata K, Narita I, Kasahara M, Shibagaki Y, Kondo M, Asahi K, Watanabe T, Tsuruya K: Serum High-Density Lipoprotein Cholesterol Levels and the Risk of Kidney Function Decline: The Japan Specific Health Checkups (J\u2011SHC) Study. J Atheroscler Thromb, 2025; 32: 407-420","DOI":"10.5551\/jat.65107"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Kuroda M, Bujo H, Yokote K, Murano T, Yamaguchi T, Ogura M, Ikewaki K, Koseki M, Takeuchi Y, Nakatsuka A, Hori M, Matsuki K, Miida T, Yokoyama S, Wada J, Harada-Shiba M: Current Status of Familial LCAT Deficiency in Japan. J Atheroscler Thromb, 2021; 28: 679-691","DOI":"10.5551\/jat.RV17051"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Pavanello C, Ossoli A, Arca M, D\u2019Erasmo L, Boscutti G, Gesualdo L, Lucchi T, Sampietro T, Veglia F, Calabresi L: Progression of chronic kidney disease in familial LCAT deficiency: a follow-up of the Italian cohort. J Lipid Res, 2020; 61: 1784-1788","DOI":"10.1194\/jlr.P120000976"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Ishibashi R, Takemoto M, Tsurutani Y, Kuroda M, Ogawa M, Wakabayashi H, Uesugi N, Nagata M, Imai N, Hattori A, Sakamoto K, Kitamoto T, Maezawa Y, Narita I, Hiroi S, Furuta A, Miida T, Yokote K: Immune-mediated acquired lecithin-cholesterol acyltransferase deficiency: A case report and literature review. J Clin Lipidol, 2018; 12: 888-897 e882","DOI":"10.1016\/j.jacl.2018.05.002"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Rohatgi A, Westerterp M, von Eckardstein A, Remaley A, Rye KA: HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research. Circulation, 2021; 143: 2293-2309","DOI":"10.1161\/CIRCULATIONAHA.120.044221"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Khera AV, Cuchel M, de la Llera-Moya M, Rodrigues A, Burke MF, Jafri K, French BC, Phillips JA, Mucksavage ML, Wilensky RL, Mohler ER, Rothblat GH, Rader DJ: Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med, 2011; 364: 127-135","DOI":"10.1056\/NEJMoa1001689"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Liu C, Zhang Y, Ding D, Li X, Yang Y, Li Q, Zheng Y, Wang D, Ling W: Cholesterol efflux capacity is an independent predictor of all-cause and cardiovascular mortality in patients with coronary artery disease: A prospective cohort study. Atherosclerosis, 2016; 249: 116-124","DOI":"10.1016\/j.atherosclerosis.2015.10.111"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Oldoni F, Baldassarre D, Castelnuovo S, Ossoli A, Amato M, van Capelleveen J, Hovingh GK, De Groot E, Bochem A, Simonelli S, Barbieri S, Veglia F, Franceschini G, Kuivenhoven JA, Holleboom AG, Calabresi L: Complete and Partial Lecithin:Cholesterol Acyltransferase Deficiency Is Differentially Associated With Atherosclerosis. Circulation, 2018; 138: 1000-1007","DOI":"10.1161\/CIRCULATIONAHA.118.034706"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Takahashi S, Hiromura K, Tsukida M, Ohishi Y, Hamatani H, Sakurai N, Sakairi T, Ikeuchi H, Kaneko Y, Maeshima A, Kuroiwa T, Yokoo H, Aoki T, Nagata M, Nojima Y: Nephrotic syndrome caused by immune-mediated acquired LCAT deficiency. J Am Soc Nephrol, 2013; 24: 1305-1312","DOI":"10.1681\/ASN.2012090913"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Komatsu T, Katsurada Y, Miyashita K, Abe S, Nishida T, Endo Y, Teramoto M, Sasaki K, Arakawa J, Sasaki M, Suzuki N, Kuwata K, Imakiire T, Miyake T, Sakurada M, Matsukuma S, Hirano T, Uehara Y, Ikewaki K: Two Cases of Acquired High-Density Lipoprotein Deficiency with Immunoglobulin G4-Related Lecithin-Cholesterol Acyltransferase Autoantibody. J Atheroscler Thromb, 2023; 30: 1070-1082","DOI":"10.5551\/jat.63616"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Takeda T, Ide T, Okuda D, Kuroda M, Asada S, Kirinashizawa M, Yamamoto M, Miyoshi J, Yokote K, Mizutani N: A novel homozygous frameshift mutation in the APOA1 gene associated with marked high-density lipoprotein deficiency. J Clin Lipidol, 2022; 16: 423-433","DOI":"10.1016\/j.jacl.2022.06.001"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Uehara Y, Ando S, Yahiro E, Oniki K, Ayaori M, Abe S, Kawachi E, Zhang B, Shioi S, Tanigawa H, Imaizumi S, Miura S, Saku K: FAMP, a novel apoA-I mimetic peptide, suppresses aortic plaque formation through promotion of biological HDL function in ApoE-deficient mice. J Am Heart Assoc, 2013; 2: e000048","DOI":"10.1161\/JAHA.113.000048"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) de la Llera-Moya M, Drazul-Schrader D, Asztalos BF, Cuchel M, Rader DJ, Rothblat GH: The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages. Arterioscler Thromb Vasc Biol, 2010; 30: 796-801","DOI":"10.1161\/ATVBAHA.109.199158"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Miida T, Kawano M, Fielding CJ, Fielding PE: Regulation of the concentration of pre beta high-density lipoprotein in normal plasma by cell membranes and lecithin-cholesterol acyltransferase activity. Biochemistry, 1992; 31: 11112-11117","DOI":"10.1021\/bi00160a022"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Kuroda M, Holleboom AG, Stroes ES, Asada S, Aoyagi Y, Kamata K, Yamashita S, Ishibashi S, Saito Y, Bujo H: Lipoprotein subfractions highly associated with renal damage in familial lecithin:cholesterol acyltransferase deficiency. Arterioscler Thromb Vasc Biol, 2014; 34: 1756-1762","DOI":"10.1161\/ATVBAHA.114.303420"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Tamaki A, Kuroda M, Yonaha K, Ishiki Y, Uehara M, Nakayama Y, Honma KI, Chinen R, Uema T, Okamoto S, Miyoshi J, Kirinashizawa M, Sato K, Aohara T, Yamamoto M, Maezawa Y, Yokote K, Masuzaki H: A Rare Case of Autoimmune-Mediated Lecithin:Cholesterol Acyltransferase Insufficiency Manifesting as the Acute Onset of Extremely Hypo-High-Density Lipoprotein-Cholesterolemia and Spontaneous Improvement: A Case Report with a Review of the Literature. J Atheroscler Thromb, 2025; 32: 649-659","DOI":"10.5551\/jat.65298"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Vitali C, Rader DJ, Cuchel M: Novel therapeutic opportunities for familial lecithin:cholesterol acyltransferase deficiency: promises and challenges. Curr Opin Lipidol, 2023; 34: 35-43","DOI":"10.1097\/MOL.0000000000000864"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Shamburek RD, Bakker-Arkema R, Auerbach BJ, Krause BR, Homan R, Amar MJ, Freeman LA, Remaley AT: Familial lecithin:cholesterol acyltransferase deficiency: First-in-human treatment with enzyme replacement. J Clin Lipidol, 2016; 10: 356-367","DOI":"10.1016\/j.jacl.2015.12.007"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Aso M, Yamamoto TT, Kuroda M, Wada J, Kubota Y, Ishikawa K, Maezawa Y, Teramoto N, Tawada A, Asada S, Aoyagi Y, Kirinashizawa M, Onitake A, Matsuura Y, Yasunaga K, Konno SI, Nishino K, Yamamoto M, Miyoshi J, Kobayashi N, Tanio M, Ikeuchi T, Igari H, Mitsukawa N, Hanaoka H, Yokote K, Saito Y: First-in-human autologous implantation of genetically modified adipocytes expressing LCAT for the treatment of familial LCAT deficiency. Heliyon, 2022; 8: e11271","DOI":"10.1016\/j.heliyon.2022.e11271"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) von Eckardstein A, Huang Y, Wu S, Funke H, Noseda G, Assmann G: Reverse cholesterol transport in plasma of patients with different forms of familial HDL deficiency. Arterioscler Thromb Vasc Biol, 1995; 15: 691-703","DOI":"10.1161\/01.ATV.15.5.691"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Berard AM, Clerc M, Brewer B, Jr., Santamarina-Fojo S: A normal rate of cellular cholesterol removal can be mediated by plasma from a patient with familial lecithin-cholesterol acyltransferase (LCAT) deficiency. Clin Chim Acta, 2001; 314: 131-139","DOI":"10.1016\/S0009-8981(01)00689-1"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Shamburek RD, Bakker-Arkema R, Shamburek AM, Freeman LA, Amar MJ, Auerbach B, Krause BR, Homan R, Adelman SJ, Collins HL, Sampson M, Wolska A, Remaley AT: Safety and Tolerability of ACP-501, a Recombinant Human Lecithin:Cholesterol Acyltransferase, in a Phase 1 Single-Dose Escalation Study. Circ Res, 2016; 118: 73-82","DOI":"10.1161\/CIRCRESAHA.115.306223"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Simonelli S, Gianazza E, Mombelli G, Bondioli A, Ferraro G, Penco S, Sirtori CR, Franceschini G, Calabresi L: Severe high-density lipoprotein deficiency associated with autoantibodies against lecithin:cholesterol acyltransferase in non-Hodgkin lymphoma. Arch Intern Med, 2012; 172: 179-181","DOI":"10.1001\/archinternmed.2011.661"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Ayaori M, Sawada S, Yonemura A, Iwamoto N, Ogura M, Tanaka N, Nakaya K, Kusuhara M, Nakamura H, Ohsuzu F: Glucocorticoid receptor regulates ATP-binding cassette transporter-A1 expression and apolipoprotein-mediated cholesterol efflux from macrophages. Arterioscler Thromb Vasc Biol, 2006; 26: 163-168","DOI":"10.1161\/01.ATV.0000193513.29074.52"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Miarka P, Idzior-Walus B, Kuzniewski M, Walus-Miarka M, Klupa T, Sulowicz W: Corticosteroid treatment of kidney disease in a patient with familial lecithin-cholesterol acyltransferase deficiency. Clin Exp Nephrol, 2011; 15: 424-429","DOI":"10.1007\/s10157-011-0409-1"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Chindhy S, Joshi P, Khera A, Ayers CR, Hedayati SS, Rohatgi A: Impaired Renal Function on Cholesterol Efflux Capacity, HDL Particle Number, and Cardiovascular Events. J Am Coll Cardiol, 2018; 72: 698-700","DOI":"10.1016\/j.jacc.2018.05.043"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/32\/12\/32_65784\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:20:47Z","timestamp":1764994847000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/32\/12\/32_65784\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.65784","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"article-number":"65784"}}